Tag Archives: NICE

The UK's New "Revolutionary" Medicines Optimization Plan

By Guest Blogger | Published: May 21, 2013
By Leela Barham. The UK’s Royal Pharmaceutical Society has joined forces with a number of other organizations, including the Association of the British Pharmaceutical Industry (ABPI), to issue new guidance on medicines optimization.  Sir Bruce Keogh, Medical Director of NHS England, says it could be revolutionary.
Posted in Europe, Global, Guest Blog, Op-Ed | Also tagged , , , , , | Leave a comment

Tough Times Ahead for New Medicines under NHS England?

By Guest Blogger | Published: April 22, 2013
By Leela Barham You’d be forgiven for missing it with the vast array of new agencies and the policy documents, guidance, consultations and ‘engagement’ activity they’re doing on in the ‘new’ NHS in England, but on the 4th April NHS England (formerly the NHS Commissioning Board) set out 15 commissioning policies in 250 pages.  They’re important, [...]
Posted in Europe, Global, Guest Blog, healthcare, pricing | Also tagged , , , , | Leave a comment

England's Cancer Drug Fund: An Acid Test for Value Based Pricing

By Guest Blogger | Published: April 12, 2013
By Leela Barham. England’s Cancer Drugs Fund (CDF) could be in its final financial year, after running in full since April 2011.  The fund covers the cost of cancer treatments either when NICE has said ‘no’, or hasn’t yet come to a view.  Companies can’t circumvent NICE though; if a company was invited to submit to [...]
Posted in Europe, Global, Guest Blog, Op-Ed, pricing | Also tagged , , , , | Leave a comment

NICE: What the New Compliance Regime Will Mean for Pharma

By Guest Blogger | Published: September 21, 2012
By Martin Smith and Tim Suter. A recent decision by the Department of Health (DoH) to introduce a compliance regime for NICE (National Institute for Health and Clinical Excellence) technology appraisals will open the door to ensuring better implementation by NHS Trusts and Joint Prescribing Groups of NICE guidance. Importantly, the regime will also open new avenues [...]
Posted in Global, Guest Blog, Regulatory | Also tagged , , , | Leave a comment

IPAB : An HCR Acronym You Need to Understand

By Guest Blogger | Published: June 1, 2011
Tom Norton throws some light on the much-vaunted Independent Payment Advisory Board. Working towards our top issue for the June edition of the HCR Monthly Review, I continue to be struck by the amount of macroeconomic data that will be driving the new HCR law. Indeed, most of the key performance measures in the 2010 statute [...]
Posted in Regulatory, healthcare | Also tagged , , , , , | 2 Comments